文献速递产科

氨甲环酸治疗出血:远不止产后出血的一种治疗手段

Tranexamic acid for bleeding: Much more than a treatment for postpartum hemorrhage.
PubMed 文献 · Am J Obstet Gynecol MFM · 2022-08-19

早期氨甲环酸治疗降低产后出血死亡的证据对全球产科护理有重大意义。氨甲环酸也可能用于预防产后出血,但风险与获益的平衡尚需更多证据。多数产后出血死亡发生在中低收入国家,氨甲环酸治疗常不可及;多个孕产妇健康组织正努力提高可及性。更广泛证据显示氨甲环酸还可通过减少月经过多、手术出血和输血需求等改善孕产妇健康。

要点

  • 早期氨甲环酸治疗可降低产后出血死亡,对全球产科护理有重大意义。
  • 氨甲环酸用于预防产后出血可能有效,但风险与获益的平衡尚需更多证据。
  • 氨甲环酸减少月经过多或可降低孕产妇贫血患病率,但需进一步临床试验。

核心结论

  • 早期氨甲环酸治疗降低产后出血死亡的证据对全球产科护理有重大意义。
  • 氨甲环酸可能对预防产后出血有作用,但风险与获益的平衡尚需更多证据。
  • 提高氨甲环酸可及性的努力应认可其在产科出血之外的其他健康获益,并旨在更广泛地增加其在各卫生服务中的使用。

研究设计与样本

  • 原文为叙述性综述,未报告系统检索范围。

主要发现

  • 多数产后出血死亡发生在中低收入国家,氨甲环酸治疗常不可及。
  • 多个孕产妇健康组织正努力提高氨甲环酸可及性。
  • 氨甲环酸通过减少月经过多或可降低孕产妇贫血患病率。
  • 氨甲环酸通过减少手术出血和输血需求,可在血源短缺国家增加血液可用性。
  • 在无血源短缺国家,氨甲环酸使用可降低医疗费用并预防输血传播感染和反应。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 氨甲环酸用于预防产后出血的风险与获益平衡尚需更多证据。
  • 氨甲环酸治疗月经过多需进一步临床试验。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

The evidence that early tranexamic acid treatment reduces postpartum hemorrhage deaths has major implications for obstetrical care worldwide. Tranexamic acid may also have a role in the prevention of postpartum hemorrhage, but more evidence is needed on the balance of risks and benefits. Most deaths from postpartum hemorrhage are in low- and middle-income countries where tranexamic acid treatment is often unavailable. Several maternal health organizations including the Reproductive Health Supplies Coalition, Clinton Health Access Initiative, Concept Foundation, International Federation of Gynecology and Obstetrics, and Unitaid are working to increase access. However, a wider view of the evidence on tranexamic acid and bleeding shows that it can improve maternal health in many other ways. An appreciation of these other health benefits could facilitate efforts to increase access. By reducing heavy menstrual bleeding, tranexamic acid could reduce the prevalence of maternal anemia, a common and important risk factor for postpartum hemorrhage and other maternal and neonatal outcomes. Further clinical trials of tranexamic acid for the treatment of menstrual bleeding are needed. By reducing surgical bleeding and the need for blood transfusion, tranexamic acid would increase the availability of blood in countries where there is blood shortage so that more blood is available for use in life-threatening bleeding including postpartum hemorrhage. In countries where there is no blood shortage, tranexamic acid use would reduce healthcare costs and prevent transfusion-transmitted infections and reactions. Trauma affects women and men, and violence is a leading cause of death in pregnancy. Increased use of tranexamic acid in trauma would significantly reduce trauma deaths. Efforts to increase the availability and use of tranexamic acid for obstetrical hemorrhage should acknowledge its other health benefits and aim to increase its use across health services more generally.

来源:Am J Obstet Gynecol MFM,查看原文。版权归原作者所有。

引用

  1. Roberts I, Brenner A, Shakur-Still H, et al. Tranexamic acid for bleeding: Much more than a treatment for postpartum hemorrhage. Am J Obstet Gynecol MFM. 2022. PMID: 35988879. doi:10.1016/j.ajogmf.2022.100722

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。